Skip to content

Mineralys Therapeutics, Inc.

MLYS· NasdaqCore metricsCIK 1933414

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -4.02%
Market cap
$1.37B
88.56M shares
Filings
408
—
—
—
-$57.33M
Q3 2026N/M FY25 yoy
-$60.09M
Q3 2026N/M FY25 yoy
-$142.43M
FY 2025derivedN/M FY25 yoy
-$0.64
Q3 2026N/M FY25 yoy
$101.27M
Q3 2026+51.6% FY25 yoy
$1.37B
—
—
2.7×
-10.38%
—

FY2025 figures · derived

Price

$15.5067.10%$31.61past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$132.01MFY 2025
$168.58M0FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$132,009,000reported
FY 20242024-12-31$168,581,000reported
FY 20232023-12-31$70,361,000reported
FY 20222022-12-31$26,250,000reported

Pharmaceutical preparations

Mineralys Therapeutics, Inc. is the 125th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Mineralys Therapeutics, Inc. · CIK 1933414 · Engraved from SEC EDGAR